Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort

Atherosclerosis

Volumn 238, Issue 2, 2015, Pages 420-426

  Hagström, Emil ^a   Ahlström, Tommy ^a,b   Ärnlöv, Johan ^a   Larsson, Anders ^a   Melhus, Håkan ^a   Hellman, Per ^a   Lind, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

Author keywords

Blood pressure; Calcium; Parathyroid hormone; Vascular function; Vascular stiffness

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITROPRUSSIDE SODIUM; PARATHYROID HORMONE; BIOLOGICAL MARKER; PTH PROTEIN, HUMAN;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BRACHIAL ARTERY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; COMMON CAROTID ARTERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; PARATHYROID HORMONE BLOOD LEVEL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; AGE; AGED; ARTERIAL PRESSURE; ASYMPTOMATIC DISEASE; BLOOD; FEMALE; MALE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SWEDEN; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

AGE FACTORS; AGED; ARTERIAL PRESSURE; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CALCIUM; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; VASCULAR DISEASES; VASCULAR STIFFNESS;

EID: 84920180124     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.12.027     Document Type: Article

References (47)

1. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J.Am. Soc. Nephrol. 2004, 15:2208-2218.
2. Garcia de la Torre N., Wass J.A., Turner H.E. Parathyroid adenomas and cardiovascular risk. Endocr. Relat. Cancer 2003, 10:309-322.
3. Nilsson I.L., Aberg J., Rastad J., Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999, 126:1049-1055.
4. Nilsson I.L., Rastad J., Johansson K., Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001, 130:986-990.
5. Rashid G., Bernheim J., Green J., Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am. J. Physiol. Ren. Physiol. 2007, 292:F1215-F1218.
6. Vestergaard P., Mollerup C.L., Frokjaer V.G., Christiansen P., Blichert-Toft M., Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J. Surg. 2003, 27:216-222.
7. Wareham N.J., Byrne C.D., Carr C., Day N.E., Boucher B.J., Hales C.N. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 1997, 46:1171-1177.
8. Jorde R., Sundsfjord J., Fitzgerald P., Bonaa K.H. Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 1999, 34:484-490.
9. Jorde R., Svartberg J., Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J.Hypertens. 2005, 23:1639-1644.
10. Hagstrom E., Michaelsson K., Melhus H., Hansen T., Ahlstrom H., Johansson L., Ingelsson E., Sundstrom J., Lind L., Arnlov J. Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts. Arterioscler. Thromb. Vasc. Biol. Jul 2014, 34(7):1567-1573.
11. Hagstrom E., Ingelsson E., Sundstrom J., Hellman P., Larsson T.E., Berglund L., Melhus H., Held C., Michaelsson K., Lind L., Arnlov J. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur. J. Heart Fail. 2010, 12:1186-1192.
12. Lind L., Skarfors E., Berglund L., Lithell H., Ljunghall S. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J.Clin. Epidemiol. 1997, 50:967-973.
13. Hagstrom E., Hellman P., Larsson T.E., Ingelsson E., Berglund L., Sundstrom J., Melhus H., Held C., Lind L., Michaelsson K., Arnlov J. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
14. Bosworth C., Sachs M.C., Duprez D., Hoofnagle A.N., Ix J.H., Jacobs D.R., Peralta C.A., Siscovick D.S., Kestenbaum B., de Boer I.H. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin. Endocrinol. Oxf. 2013, 79:429-436.
15. Lind L., Fors N., Hall J., Marttala K., Stenborg A. Acomparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2368-2375.
16. Eggers K.M., Lindahl B., Venge P., Lind L. B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years. Am. J. Cardiol. 2009, 103:1032-1038.
17. Lind L., Fors N., Hall J., Marttala K., Stenborg A. Acomparison of three different methods to determine arterial compliance in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. J.Hypertens. 2006, 24:1075-1082.
18. Lind L., Andren B., Sundstrom J. The stroke volume/pulse pressure ratio predicts coronary heart disease mortality in a population of elderly men. J.Hypertens. 2004, 22:899-905.
19. Nuzzo V., Tauchmanova L., Fonderico F., Trotta R., Fittipaldi M.R., Fontana D., Rossi R., Lombardi G., Trimarco B., Lupoli G. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur. J. Endocrinol. 2002, 147:453-459.
20. Baykan M., Erem C., Erdogan T., Hacihasanoglu A., Gedikli O., Kiris A., Kucukosmanoglu M., Ersoz H.O., Celik S. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int. J. Cardiovasc. Imaging 2007, 23:323-328.
21. Luigi P., Chiara F.M., Laura Z., Cristiano M., Giuseppina C., Luciano C., Giuseppe P., Sabrina C., Susanna S., Antonio C., Giuseppe C., Giorgio de T., Claudio L. Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results. Int. J. Endocrinol. 2012, 2012:408295.
22. Schillaci G., Pucci G., Pirro M., Monacelli M., Scarponi A.M., Manfredelli M.R., Rondelli F., Avenia N., Mannarino E. Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 2011, 218:96-101.
23. Smith J.C., Page M.D., John R., Wheeler M.H., Cockcroft J.R., Scanlon M.F., Davies J.S. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J.Clin. Endocrinol. Metab. 2000, 85:3515-3519.
24. Broulik P.D., Broulikova A., Adamek S., Libansky P., Tvrdon J., Broulikova K., Kubinyi J. Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism. Int. J. Endocrinol. 2011, 2011:309068.
25. Neunteufl T., Heher S., Prager G., Katzenschlager R., Abela C., Niederle B., Stefenelli T. Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin. Endocrinol. Oxf. 2000, 53:229-233.
26. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434-2439.
27. Temmar M., Liabeuf S., Renard C., Czernichow S., Esper N.E., Shahapuni I., Presne C., Makdassi R., Andrejak M., Tribouilloy C., Galan P., Safar M.E., Choukroun G., Massy Z. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J.Hypertens. 2010, 28:163-169.
28. Farahnak P., Lind L., Mattala K., Nilsson I.L. Parathyroid hormone's acute effect on vasodilatory function. Clin. Med. Insights Endocrinol. Diabetes 2010, 3:37-42.
29. Hulter H.N., Melby J.C., Peterson J.C., Cooke C.R. Chronic continuous PTH infusion results in hypertension in normal subjects. J.Clin. Hypertens. 1986, 2:360-370.
30. Rubin M.R., Rundek T., McMahon D.J., Lee H.S., Sacco R.L., Silverberg S.J. Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis 2007, 194:426-432.
31. Payne M.E., Pierce C.W., McQuoid D.R., Steffens D.C., Anderson J.J. Serum ionized calcium may be related to white matter lesion volumes in older adults: a pilot study. Nutrients 2013, 5:2192-2205.
32. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur. J. Cardiovasc Prev. Rehabil. 2004, 11:69-74.
33. Hagström Emil, Kilander L., Nylander Ruta, Larsson Elna-Marie, Michaelsson Karl, Melhus Håkan, Ahlström Håkan, Johansson Lars, Lind Lars, Ärnlov Johan Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community based cohorts. J.Clin. Endocrinol. Metab. Nov 2014, 99(11):4181-4189.
34. Amann K., Tornig J., Flechtenmacher C., Nabokov A., Mall G., Ritz E. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH. Nephrol. Dial. Transpl. 1995, 10:2043-2048.
35. Walker M.D., Fleischer J., Rundek T., McMahon D.J., Homma S., Sacco R., Silverberg S.J. Carotid vascular abnormalities in primary hyperparathyroidism. J.Clin. Endocrinol. Metab. 2009, 94:3849-3856.
36. Perkovic V., Hewitson T.D., Kelynack K.J., Martic M., Tait M.G., Becker G.J. Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press. Res. 2003, 26:27-33.
37. Busse R., Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 1990, 265:133-136.
38. Saleh F.N., Schirmer H., Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur. Heart J. 2003, 24:2054-2060.
39. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur. J. Endocrinol. 2004, 151:167-172.
40. Ogard C.G., Engelmann M.D., Kistorp C., Nielsen S.L., Vestergaard H. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin. Endocrinol. Oxf. 2005, 63:493-498.
41. Vassalotti J.A., Uribarri J., Chen S.C., Li S., Wang C., Collins A.J., Calvo M.S., Whaley-Connell A.T., McCullough P.A., Norris K.C. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008, 51:S56-S68.
42. Jorde R., Sundsfjord J., Bonaa K.H. Determinants of serum calcium in men and women. The Tromso Study. Eur. J. Epidemiol. 2001, 17:1117-1123.
43. Larsson T.E., Olauson H., Hagstrom E., Ingelsson E., Arnlov J., Lind L., Sundstrom J. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler. Thromb. Vasc. Biol. 2010, 30:333-339.
44. Kestenbaum B., Katz R., de Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., Jenny N.S., Siscovick D.S. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J.Am. Coll. Cardiol. 2011, 58:1433-1441.
45. Maggio M., De Vita F., Lauretani F., Paolo Ceda G., Volpi E., Giallauria F., De Cicco G., Cattabiani C., Melhus H., Michaelsson K., Cederholm T., Lind L. Vitamin D and endothelial vasodilation in older individuals: data from the PIVUS Study. J.Clin. Endocrinol. Metab. Sep 2014, 99(9):3382-3389. jc20141536.
46. Lind L., Andersson J., Hansen T., Johansson L., Ahlstrom H. Atherosclerosis measured by whole body magnetic resonance angiography and carotid artery ultrasound is related to arterial compliance, but not to endothelium-dependent vasodilation - the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Clin. Physiol. Funct. Imaging 2009, 29:321-329.
47. van Sloten T.T., Schram M.T., van den Hurk K., Dekker J.M., Nijpels G., Henry R.M., Stehouwer C.D. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J.Am. Coll. Cardiol. 2014, 63:1739-1747.